Cargando…

Role of Human Organic Cation Transporter 1 (hOCT1) Polymorphisms in Lamivudine (3TC) Uptake and Drug-Drug Interactions

Lamivudine (3TC), a drug used in the treatment of HIV infection, needs to cross the plasma membrane to exert its therapeutic action. Human Organic cation transporter 1 (hOCT1), encoded by the SLC22A1 gene, is the transporter responsible for its uptake into target cells. As SLC22A1 is a highly polymo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arimany-Nardi, Cristina, Minuesa, Gerard, Keller, Thorsten, Erkizia, Itziar, Koepsell, Hermann, Martinez-Picado, Javier, Pastor-Anglada, Marçal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919327/ https://www.ncbi.nlm.nih.gov/pubmed/27445813 http://dx.doi.org/10.3389/fphar.2016.00175

Ejemplares similares

P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gp(high) cells and correlates with HIV-1 viral load
por: Minuesa, Gerard, et al.
Publicado: (2016)

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
por: Galimberti, Sara, et al.
Publicado: (2017)

Entecavir Interacts with Influx Transporters hOAT1, hCNT2, hCNT3, but Not with hOCT2: The Potential for Renal Transporter-Mediated Cytotoxicity and Drug–Drug Interactions
por: Mandíková, Jana, et al.
Publicado: (2016)

Effects of Single Nucleotide Polymorphism Ala270Ser (rs316019) on the Function and Regulation of hOCT2
por: Frenzel, Dominik, et al.
Publicado: (2019)

Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
por: Pastor-Anglada, Marçal, et al.
Publicado: (2015)

Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)
por: Ceckova, Martina, et al.
Publicado: (2018)

DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
por: Schaeffeler, Elke, et al.
Publicado: (2011)

Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs
por: Pérez-Torras, Sandra, et al.
Publicado: (2012)

Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma
por: Urtasun, Nerea, et al.
Publicado: (2017)

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
por: Andreev, Emil, et al.
Publicado: (2016)

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1
por: Boces-Pascual, Clara, et al.
Publicado: (2021)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2
por: Suo, Yang, et al.
Publicado: (2023)

Emerging Roles of Nucleoside Transporters
por: Pastor-Anglada, Marçal, et al.
Publicado: (2018)

Who Is Who in Adenosine Transport
por: Pastor-Anglada, Marçal, et al.
Publicado: (2018)

Drug-Drug Interactions at Organic Cation Transporter 1
por: Zhou, Shiwei, et al.
Publicado: (2021)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia
por: Nishizawa, Kei, et al.
Publicado: (2019)

In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection
por: Dalmau, Judith, et al.
Publicado: (2012)

Long Term Endocrine Regulation of Nucleoside Transporters in Rat Intestinal Epithelial Cells
por: Aymerich, Ivette, et al.
Publicado: (2004)

Mechanisms Implicated in the Response of System A to Hypertonic Stress and Amino Acid Deprivation Still Can Be Different
por: Pastor-Anglada, Marçal, et al.
Publicado: (2005)

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection
por: Boffito, Marta, et al.
Publicado: (2020)

High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3
por: Chen, Eugene C., et al.
Publicado: (2022)

Organic Anion and Cation SLC22 “Drug” Transporter (Oat1, Oat3, and Oct1) Regulation during Development and Maturation of the Kidney Proximal Tubule
por: Gallegos, Thomas F., et al.
Publicado: (2012)

The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein
por: Rodriguez-Plata, Maria T, et al.
Publicado: (2013)

Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)
por: Pastor-Anglada, Marçal, et al.
Publicado: (2022)

A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug–Drug–Gene Interaction Predictions
por: Türk, Denise, et al.
Publicado: (2020)

Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
por: Meyer, Marleen Julia, et al.
Publicado: (2022)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011)

Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)
por: Troya, Jesús, et al.
Publicado: (2023)

2842. Durable Efficacy of Two-Drug Regimen (2DR) of Dolutegravir (DTG) plus Lamivudine (3TC) in Antiretroviral Treatment-Naïve Adults with HIV-1 Infection at 96 Weeks: Subgroup Analyses in the GEMINI Studies
por: van Wyk, Jean A, et al.
Publicado: (2019)

Drug-Drug Interaction of Ergotamine with a Combination of Darunavir, Abacavir, and Lamivudine Causing a Fatal Vasospastic Ischemia
por: Petit, Elisabeth, et al.
Publicado: (2018)

London Prices of Drugs.—Oct. 22
Publicado: (1813)

Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report
por: Kakubu, Mireille A M, et al.
Publicado: (2023)

Microparticles of Lamivudine—Poly-ε-Caprolactone Conjugate for Drug Delivery via Internalization by Macrophages
por: Urbaniak, Tomasz, et al.
Publicado: (2019)

Abacavir/dolutegravir/lamivudine: Delayed hepatotoxicity and drug-induced liver injury: case report
Publicado: (2021)

In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs
por: George, Blessy, et al.
Publicado: (2021)

HIV and Mature Dendritic Cells: Trojan Exosomes Riding the Trojan Horse?
por: Izquierdo-Useros, Nuria, et al.
Publicado: (2010)

Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
por: Dueñas-Gutiérrez, Carlos, et al.
Publicado: (2023)

Transcription factor organic cation transporter 1 (OCT-1) affects the expression of porcine Klotho (KL) gene
por: Li, Yan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1jav7hngcle4fnc1tjshopo63t